ESR1 and breast carcinoma: Ichikawa et al., reported that SYT13 overexpression in estrogen receptor (ER)-positive breast cancer correlated with several key oncogenes, including estrogen receptor 1 (ER1), Akt, and cyclin-dependent kinases 4 (CDK4) [46].